Literature DB >> 20331960

Developing a global agenda for sickle cell disease: report of an international symposium and workshop in Cotonou, Republic of Benin.

Isaac Odame1.   

Abstract

Sickle cell disease (SCD) is one of the most common monogenetic diseases worldwide. Although there have been some advances in the management of SCD in high-income countries, much remains to be learned about the mechanisms underlying the wide phenotypic diversity of the disease. In low-income countries, basic facilities for management are lacking, systematic screening is not common practice, and diagnosis is made late. The case has been made for the need to develop long-term partnerships between SCD clinicians and researchers in high- and low-income countries in order to further research and improve clinical care globally. In response to this critical need, a meeting of SCD experts from around the world was held in Cotonou, Republic of Benin, on January 26-29, 2009. The meeting was entitled "Advancing Sickle Cell Disease Patient Care Through Global Research." In addition to plenary sessions, small study groups discussed the following topics: the natural history of SCD in Africa and elsewhere, neonatal screening programs, infectious diseases in SCD, hydroxyurea therapy in Africa and other regions, and genetic factors involved in phenotypic diversity. A roundtable discussion on experience with collaborative programs to establish SCD centers in low-income countries highlighted steps that are necessary to establish these programs and the problems that have been encountered. During a session on capacity building, small study groups consisting of participants from low-, middle-, and high-income countries discussed collaborations for the identification, clinical care, and study of SCD patients in low-income countries. There was agreement to establish the Global Sickle Cell Disease Network to foster a global community to advance the clinical care and study of patients with SCD. The next meeting of the network will take place in Accra, Ghana, on July 20-23, 2010. Copyright 2010 American Journal of Preventive Medicine. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2010        PMID: 20331960     DOI: 10.1016/j.amepre.2009.12.021

Source DB:  PubMed          Journal:  Am J Prev Med        ISSN: 0749-3797            Impact factor:   5.043


  10 in total

1.  Point-of-care end-tidal carbon monoxide reflects severity of hemolysis in sickle cell anemia.

Authors:  Ashutosh Lal; Lasandra Patterson; Alisa Goldrich; Anne Marsh
Journal:  Pediatr Blood Cancer       Date:  2015-02-14       Impact factor: 3.167

Review 2.  Improving outcomes in children with sickle cell disease: treatment considerations and strategies.

Authors:  Ali Amid; Isaac Odame
Journal:  Paediatr Drugs       Date:  2014-08       Impact factor: 3.022

Review 3.  Hydroxyurea for sickle cell anemia: what have we learned and what questions still remain?

Authors:  Patrick T McGann; Russell E Ware
Journal:  Curr Opin Hematol       Date:  2011-05       Impact factor: 3.284

Review 4.  Sickle cell disease.

Authors:  Martin M Meremikwu; Uduak Okomo
Journal:  BMJ Clin Evid       Date:  2016-01-22

5.  Haematology in Africa.

Authors:  Lucio Luzzatto; Foluke Fasola; Léon Tshilolo
Journal:  Br J Haematol       Date:  2011-07-05       Impact factor: 6.998

6.  The burden and consequences of inherited blood disorders among young children in western Kenya.

Authors:  Parminder S Suchdev; Laird J Ruth; Marie Earley; Alex Macharia; Thomas N Williams
Journal:  Matern Child Nutr       Date:  2012-09-13       Impact factor: 3.092

7.  [Psychosocial impact of sickle cell disease in the parents of children living in Kinshasa, Democratic Republic of Congo: a qualitative study].

Authors:  Evariste Luboya; Jean-Christophe Bukasa Tshilonda; Mathilde Bothale Ekila; Michel Ntetani Aloni
Journal:  Pan Afr Med J       Date:  2014-09-02

8.  Hydroxyurea Therapy for Children With Sickle Cell Anemia in Sub-Saharan Africa: Rationale and Design of the REACH Trial.

Authors:  Patrick T McGann; Léon Tshilolo; Brigida Santos; George A Tomlinson; Susan Stuber; Teresa Latham; Banu Aygun; Stephen K Obaro; Peter Olupot-Olupot; Thomas N Williams; Isaac Odame; Russell E Ware
Journal:  Pediatr Blood Cancer       Date:  2015-08-14       Impact factor: 3.167

9.  The Need for Hematology Nurse Education in Low- and Middle-Income Countries: A Community Case Study in Tanzania.

Authors:  Julie M Buser
Journal:  Front Public Health       Date:  2017-03-29

10.  Enablers and barriers to newborn screening for sickle cell disease in Africa: results from a qualitative study involving programmes in six countries.

Authors:  Natasha M Archer; Baba Inusa; Julie Makani; Siana Nkya; Léon Tshilolo; Venee N Tubman; Patrick T McGann; Emmanuela Eusebio Ambrose; Natalie Henrich; Jonathan Spector; Kwaku Ohene-Frempong
Journal:  BMJ Open       Date:  2022-03-09       Impact factor: 2.692

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.